跳至主要内容
临床试验/NCT05153655
NCT05153655已完成不适用

Safety and Tolerability of Local Ischemic Post-conditioning in Patients With Acute Ischemic Stroke After Mechanical Thrombectomy

Capital Medical University1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2021年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
1
主要终点
Number of participants with major response

研究概览

简要总结

Ischemic post-conditioning is a neuroprotective strategy that has been proven to attenuate reperfusion injury in animal models of stroke. The purpose of this proof-of-concept study is to determine the safety and tolerability of ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80 years;
  • Acute ischemic stroke caused by middle cerebral artery M1 segment occlusion;
  • Successful recanalization (mTICI 2b/3) after endovascular thrombectomy that confirmed by digital subtraction angiography;
  • Written informed consent provided by the patients or their legal relatives.

排除标准

  • Known diagnosis or clinical suspicion of cerebral vasculitis or fibromuscular dysplasia;
  • Difficulty in reaching the designated position of the balloon used for ischemic post-conditioning;
  • Stenting in the middle cerebral artery as rescue therapy during the thrombectomy procedures;
  • > 2 times of balloon dilations as rescue therapy due to angioplasty during the thrombectomy procedures;
  • Moderate or severe residual stenosis (≥ 50%) of the culprit artery after recanalization;
  • Difficulty in complying with ischemic post-conditioning or other conditions that the investigator considered inappropriate for inclusion.

结局指标

主要结局

Number of participants with major response

时间窗: Immediately after intervention on the day of ischemic post-conditioning

Major response is any of the following: * Vessel perforation or rupture; * Reocclusion of the culprit vessel after post-conditioning; * Vessel dissection; * Severe vasospasm; * Ischemic post-conditioning related thrombotic events; * Rupture of the balloon used for post-conditioning. In the 3 + 3 design, 3 subjects are recruited for a given ischemic post-conditioning dose level. The trial is stopped if ≥ 2 of 3 subjects at a given dose level show major response. If only 1 of 3 subjects shows major response, 3 more subjects are recruited at a given dose level and a major response in any of them will stop the trial. Otherwise, same procedure is followed for the next ischemic post-conditioning dose level. Maximum tolerable dose will be the dose at the level before stopping of the trial.

次要结局

未报告次要终点

研究者

发起方
Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ji Xunming,MD,PhD

Professor

Capital Medical University

研究点 (1)

Loading locations...

相似试验